Coincidentally, so is Oncosec. The volume and trend has been down because from what I can make out of it, the talk is companies are waiting to #$%$ the impact of Obamacare. Not getting political here-it just is what it is. I have mentioned before that one of the tax increases of this program is to target medical device sales. There are on-going discussions with capital hill to overturn this idea, due to economic impact of driving device production over seas. This has got to be weighing in as part of the delay with partnering but it's only best guess at this point. Would love to speak with the great and powerful Oz behind all of this.
Good thought, but considering ONCS can only market overseas, China, EU, Australia, I would imagine the delivery device would be manufactured overseas also. The tax is idiotic in the first place, job killer! But, whats new?